A 29-year-old woman without HIV risk factors asks about HIV prevention for her partner, a man who has sex with men with multiple partners. Which is an evidence-based PrEP option for at-risk individuals?ADaily emtricitabine/tenofovir disoproxil fumarate (TDF/FTC)BDaily emtricitabine/tenofovir alafenamide (TAF/FTC) for receptive vaginal sexCLong-acting cabotegravir injections every 12 monthsDEvent-driven (2-1-1) TDF/FTC in cisgender womenEDaily lopinavir/ritonavirCheck my answer